Key indicators: single-crystal X-ray study; T = 90 K; mean (C-C) = 0.003 Å; disorder in main residue; R factor = 0.043; wR factor = 0.115; data-to-parameter ratio = 15.5.
The title compound, C 35 H 53 NO 5 ÁCH 3 OH {systematic name: (3S,6E,8S,9R,10E,12S,13S,14E,16S,17R)-3-benzyl-9, 13-dihydroxy-6,8,10,12,14,16-hexamethyl-17-[(2S,4S )-4-methylhexan-2-yl]-1-oxa-4-azacycloheptadeca-6,10,14-triene-2,5-dione methanol-d 4 monosolvate}, was extracted from conidia of the fungus Metarhizium acridum. Crystals were obtained as a methanol-d 4 solvate. The tail part of the 4-methylhexan-2-yl group exhibits disorder over two positions, with an occupancy ratio of 0.682 (9):0.318 (9). The crystal structure confirms the absolute configuration of nine stereocenters determined previously for the acetylated compound metacridamide A. In the crystal, the methanol-d4 molecule is positioned close to the O atom in the carbonyl group of the peptide bond, forming an O-HÁ Á ÁO hydrogen bond. It also forms an O-HÁ Á ÁO hydrogen bond with an adjacent molecule. N-HÁ Á ÁO and O-HÁ Á ÁO hydrogen bonds are observed between neighboring molecules.
Related literature
For details of the isolation and purification of the title compound, see: Krasnoff et al. (2012) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). Symmetry codes: (i) x þ 1; y; z; (ii) x; y þ 1; z; (iii) x À 1; y; z. 
Figure 1
The molecular structure of the title compound with displacement ellipsoids drawn at 50% probability level. The atoms of the minor disordered component C20B-C22B have been omitted for clarity. (3S,6E,8S,9R,10E,12S,13S,14E,16S,17R) 0.0195 (7) 0.0280 (7) 0.0287 (7 
